U.S. flag

An official website of the United States government

NM_001134407.3(GRIN2A):c.3211C>T (p.His1071Tyr) AND Landau-Kleffner syndrome

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Oct 19, 2022
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000554587.9

Allele description [Variation Report for NM_001134407.3(GRIN2A):c.3211C>T (p.His1071Tyr)]

NM_001134407.3(GRIN2A):c.3211C>T (p.His1071Tyr)

Gene:
GRIN2A:glutamate ionotropic receptor NMDA type subunit 2A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.2
Genomic location:
Preferred name:
NM_001134407.3(GRIN2A):c.3211C>T (p.His1071Tyr)
HGVS:
  • NC_000016.10:g.9764333G>A
  • NG_011812.2:g.423422C>T
  • NM_000833.3:c.3211C>T
  • NM_000833.5:c.3211C>T
  • NM_001134407.3:c.3211C>TMANE SELECT
  • NM_001134408.2:c.3211C>T
  • NP_000824.1:p.His1071Tyr
  • NP_001127879.1:p.His1071Tyr
  • NP_001127880.1:p.His1071Tyr
  • NC_000016.9:g.9858190G>A
  • NG_011812.1:g.423422C>T
  • NM_000833.4:c.3211C>T
  • NM_001134407.2:c.3211C>T
Protein change:
H1071Y
Links:
dbSNP: rs1555482611
NCBI 1000 Genomes Browser:
rs1555482611
Molecular consequence:
  • NM_000833.5:c.3211C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001134407.3:c.3211C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001134408.2:c.3211C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Landau-Kleffner syndrome (FESD)
Synonyms:
Acquired aphasia with convulsive disorder; Acquired epileptiform aphasia; APHASIA, ACQUIRED, WITH EPILEPSY; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009509; MedGen: C0282512; Orphanet: 1945; Orphanet: 725; Orphanet: 98818; OMIM: 245570

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000638243Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely benign
(Oct 19, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001480303New York Genome Center - CSER-NYCKidSeq
criteria provided, single submitter

(NYGC Assertion Criteria 2020)
Uncertain significance
(Oct 10, 2019)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided1not providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV000638243.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From New York Genome Center - CSER-NYCKidSeq, SCV001480303.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

The c.3211C>T (p.His1071Tyr) variant identified in the GRIN2A gene substitutes a highly conserved Histidine for Tyrosine at amino acid 1071/1465 (coding exon 13/13). This variant is absent from gnomAD and ExAC, suggesting it is not a common benign variant in the populations represented in these databases. In silico algorithms predict this variant to be Neutral (Provean; score: 0.49) and Tolerated (SIFT; score:0.899) to the function of the canonical transcript. This variant is reported in ClinVar as Likely Benign (VarID:464058) by a single clincal lab, however the evidence supporting the Likely Benign classification is not available for our review. To our current knowledge this variant has not been reported in affected individuals in the literature. The p.His1071 residue is in the large C-terminal domain of GRIN2A. The majority of Pathogenic and Likely Pathogenic missense variants in GRIN2A are located in the ligand binding or transmembrane domians of the protein, which are N-terminal to the variant identified in this individual [PMID: 30544257], and missense variants in exon 14 are largely classified as Variants of Uncertain Significance in ClinVar. Given the lack of compelling information regarding the pathogenicity of the c.3211C>T (p.His1071Tyr) variant it is reported here as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown1not providednot provided1not providednot providednot provided

Last Updated: May 1, 2024